TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,037,312 | -1.7% | 1,296,416 | 0.0% | 0.77% | +13.3% |
Q2 2023 | $23,426,237 | +43.8% | 1,296,416 | 0.0% | 0.68% | +41.0% |
Q1 2023 | $16,295,949 | -14.3% | 1,296,416 | 0.0% | 0.48% | -9.9% |
Q4 2022 | $19,005,459 | -14.4% | 1,296,416 | 0.0% | 0.53% | -17.1% |
Q3 2022 | $22,194,000 | +17.3% | 1,296,416 | 0.0% | 0.64% | +8.6% |
Q2 2022 | $18,927,000 | -13.2% | 1,296,416 | 0.0% | 0.59% | +35.7% |
Q1 2022 | $21,805,000 | -62.6% | 1,296,416 | -50.0% | 0.44% | -2.9% |
Q4 2021 | $58,338,000 | +108.8% | 2,592,832 | +100.0% | 0.45% | +10.8% |
Q3 2021 | $27,937,000 | -62.8% | 1,296,416 | -50.0% | 0.41% | -16.8% |
Q2 2021 | $75,140,000 | +82.7% | 2,592,832 | +100.0% | 0.49% | -6.2% |
Q1 2021 | $41,127,000 | -23.2% | 1,296,416 | 0.0% | 0.52% | -9.6% |
Q4 2020 | $53,580,000 | – | 1,296,416 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |